STOKE THERAPEUTICS INC (STOK) Stock Earnings & Estimates
NASDAQ:STOK - US86150R1077 - Common Stock
20.25 USD
+0.49 (+2.48%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 12.41M | 8.78M -29.25% | 36.555M 316.34% | 188.47M 415.58% | 35.117M -81.37% | 46.325M 31.92% | 89.644M 93.51% | 251.1M 180.11% | 436.88M 73.99% | 661M 51.30% | 866.5M 31.09% | |
| EBITDA YoY % growth | -102.81M -20.81% | -112.304M -9.23% | -99.195M 11.67% | -932.79K 99.06% | -173.368M -18,486.00% | -138.876M 19.90% | -84.252M 39.33% | 80.886M 196.00% | 212.06M 162.17% | 367.4M 73.25% | 495.21M 34.79% | |
| EBIT YoY % growth | -104.36M -21.25% | -114.773M -9.98% | -101.372M 11.68% | 2.992M 102.95% | -187.793M -6,376.52% | -202.999M -8.10% | -129.104M 36.40% | -11.295M 91.25% | 166.19M 1,571.38% | 312.02M 87.75% | 445.67M 42.83% | |
| Operating Margin | -840.93% | -1,307.21% | -277.31% | 1.59% | -534.77% | -438.21% | -144.02% | -4.50% | 38.04% | 47.20% | 51.43% | |
| EPS YoY % growth | -2.60 -11.59% | -2.37 8.69% | -1.68 29.23% | 0.30 118.15% | -2.99 -1,080.08% | -2.41 19.37% | -1.49 38.38% | 0.17 111.50% | 2.72 1,494.03% | 5.41 98.50% | 7.17 32.64% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.59 -24.61% | -0.63 -251.33% | -0.61 -130.91% | -0.65 -61.73% | -0.70 -19.53% | -0.72 -14.35% |
| Revenue Q2Q % growth | 5.621M 14.85% | 4.953M -78.10% | 4.76M -97.00% | 4.845M -64.93% | 6.63M 17.95% | 6.63M 33.86% |
| EBITDA Q2Q % growth | -40.086M -41.39% | -40.698M -254.64% | -29.085M -126.03% | -32.045M -21.49% | -33.462M 16.52% | -34.696M 14.75% |
| EBIT Q2Q % growth | -39.853M -32.83% | -42.401M -210.56% | -42.364M -138.08% | -44.74M -63.88% | -45.892M -15.15% | -47.685M -12.46% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.40 13.04% | -0.52 | 0.12 | 23.41% |
| Q1 2025 Q2Q % growth | 1.98 447.37% | -0.43 | 2.41 | 558.67% |
| Q4 2024 Q2Q % growth | -0.18 70.00% | -0.54 | 0.36 | 66.58% |
| Q3 2024 Q2Q % growth | -0.47 15.16% | -0.54 | 0.07 | 13.51% |
| Q2 2024 Q2Q % growth | -0.46 33.33% | -0.57 | 0.11 | 19.47% |
| Q1 2024 Q2Q % growth | -0.57 -7.55% | -0.62 | 0.05 | 8.39% |
| Q4 2023 Q2Q % growth | -0.60 7.69% | -0.64 | 0.04 | 6.63% |
| Q3 2023 Q2Q % growth | -0.55 16.06% | -0.65 | 0.09 | 14.13% |
| Q2 2023 Q2Q % growth | -0.69 -9.52% | -0.65 | -0.04 | -6.31% |
| Q1 2023 Q2Q % growth | -0.53 19.70% | -0.71 | 0.18 | 25.38% |
| Q4 2022 Q2Q % growth | -0.65 1.52% | -0.72 | 0.07 | 9.22% |
| Q3 2022 Q2Q % growth | -0.66 -8.20% | -0.70 | 0.04 | 5.40% |
| Q2 2022 Q2Q % growth | -0.63 -5.00% | -0.70 | 0.07 | 10.20% |
| Q1 2022 Q2Q % growth | -0.66 -43.48% | 0.37 | -1.03 | -278.64% |
| Q4 2021 Q2Q % growth | -0.66 -57.14% | -0.64 | -0.02 | -3.86% |
| Q3 2021 Q2Q % growth | -0.61 -48.78% | -0.60 | -0.01 | -1.75% |
| Q2 2021 Q2Q % growth | -0.60 -53.85% | -0.48 | -0.12 | -25.16% |
| Q1 2021 Q2Q % growth | -0.46 -35.29% | -0.45 | -0.01 | -2.50% |
| Q4 2020 Q2Q % growth | -0.42 -366.67% | -0.43 | 0.01 | 1.73% |
| Q3 2020 Q2Q % growth | -0.41 -57.69% | -0.42 | 0.01 | 2.96% |
| Q2 2020 Q2Q % growth | -0.39 74.68% | -0.36 | -0.03 | -7.81% |
| Q1 2020 Q2Q % growth | -0.34 | -0.36 | 0.02 | 6.40% |
| Q4 2019 Q2Q % growth | -0.09 | -0.32 | 0.23 | 71.76% |
| Q3 2019 Q2Q % growth | -0.26 | -0.28 | 0.02 | 6.70% |
| Q2 2019 Q2Q % growth | -1.54 | -0.98 | -0.56 | -57.64% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 13.817M 186.01% | 9.089M | 4.728M | 52.02% |
| Q1 2025 Q2Q % growth | 158.569M 3,661.12% | 8.938M | 149.631M | 1,674.10% |
| Q4 2024 Q2Q % growth | 22.614M 707.35% | 4.366M | 18.248M | 417.96% |
| Q3 2024 Q2Q % growth | 4.894M 47.94% | 3.417M | 1.477M | 43.23% |
| Q2 2024 Q2Q % growth | 4.831M 294.72% | 3.321M | 1.51M | 45.47% |
| Q1 2024 Q2Q % growth | 4.216M -18.17% | 3.279M | 937K | 28.58% |
| Q4 2023 Q2Q % growth | 2.801M -14.34% | 3.315M | -514K | -15.51% |
| Q3 2023 Q2Q % growth | 3.308M 13.68% | 3.251M | 57K | 1.75% |
| Q2 2023 Q2Q % growth | -2.481M -176.81% | 3.162M | -5.643M | -178.46% |
| Q1 2023 Q2Q % growth | 5.152M 71.73% | 2.678M | 2.474M | 92.38% |
| Q4 2022 Q2Q % growth | 3.27M | 2.628M | 642K | 24.43% |
| Q3 2022 Q2Q % growth | 2.91M | 2.499M | 411K | 16.45% |
| Q2 2022 Q2Q % growth | 3.23M | 2.394M | 836K | 34.92% |
| Q1 2022 Q2Q % growth | 3M | 40.8M | -37.8M | -92.65% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.82% | 1.34% | 398.33% | 118.17% |
| Revenue | -13.3% | 92.7% | 1.27% | 257.63% |